Associated Papers
Whole-exome sequencing in children with dyslexia implicates rare variants in CLDN3 and ion channel genes.
Marianski K et al.
Human Genetics, 2025
Novel approaches for the discovery of pharmacogenetic biomarkers of chemotoxicity in patients with colorectal cancer.
Simoes AR et al.
British Journal of Pharmacology, 2025
Pharmacogenomic profile of actionable molecular variants related to drugs commonly used in anesthesia: WES analysis reveals new mutations.
Parada-Márquez JF et al.
Frontiers in Pharmacology, 2023
Decoding variants in drug-metabolizing enzymes and transporters in solid tumor patients by whole-exome sequencing.
Aboul-Soud MAM et al.
Saudi Journal of Biological Sciences, 2021
Ethnogeographic and inter-individual variability of human ABC transporters.
Xiao Q et al.
Human Genetics, 2020
Targeted next generation sequencing as a tool for precision medicine.
Gulilat M et al.
Bmc Medical Genomics, 2019
Longrange PCR-based next-generation sequencing in pharmacokinetics and pharmacodynamics study of propofol among patients under general anaesthesia.
Zakerska-Banaszak O et al.
Scientific Reports, 2017
Relationship Between ABCB1 Polymorphisms and Cold Pain Sensitivity Among Healthy Opioid-naive Malay Males.
Zahari Z et al.
Pain Practice : the Official Journal of World Institute of Pain, 2017
How well do whole exome sequencing results correlate with medical findings? A study of 89 Mayo Clinic Biobank samples.
Middha S et al.
Frontiers in Genetics, 2015
An update on ABCB1 pharmacogenetics: insights from a 3D model into the location and evolutionary conservation of residues corresponding to SNPs associated with drug pharmacokinetics.
Wolf SJ et al.
The Pharmacogenomics Journal, 2011
P-glycoprotein: tissue distribution, substrates, and functional consequences of genetic variations.
Cascorbi I
Handbook of Experimental Pharmacology, 2011
MDR1 variants and risk of Parkinson disease. Association with pesticide exposure?
Zschiedrich K et al.
Journal of Neurology, 2009
Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs.
Cascorbi I
Pharmacology & Therapeutics, 2006
MDR1 gene polymorphisms and clinical relevance.
Li YH et al.
Yi Chuan Xue Bao = Acta Genetica Sinica, 2006
Single nucleotide polymorphisms in human P-glycoprotein: its impact on drug delivery and disposition.
Dey S
Expert Opinion on Drug Delivery, 2006
[Association study between NPY and YWHAH gene polymorphisms and schizophrenia].
Wang HS et al.
Yi Chuan Xue Bao = Acta Genetica Sinica, 2005
Genetic polymorphisms of ATP-binding cassette transporters ABCB1 and ABCG2: therapeutic implications.
Sakurai A et al.
Expert Opinion on Pharmacotherapy, 2005
Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis.
Potocnik U et al.
Genes and Immunity, 2004
[Detecting genetic polymorphisms of CYP1 A1 and GSTM1 simultaneously with oligonucleotide microarray].
Liu SZ et al.
Yi Chuan Xue Bao = Acta Genetica Sinica, 2004
Pharmacogenomics of drug transporters: a new approach to functional analysis of the genetic polymorphisms of ABCB1 (P-glycoprotein/MDR1).
Ishikawa T et al.
Biological & Pharmaceutical Bulletin, 2004
The MDR1 (ABCB1) gene polymorphism and its clinical implications.
Ieiri I et al.
Clinical Pharmacokinetics, 2004
The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans.
Fromm MF
Advanced Drug Delivery Reviews, 2002
MDR1 genotype-related pharmacokinetics and pharmacodynamics.
Sakaeda T et al.
Biological & Pharmaceutical Bulletin, 2002
Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects.
Cascorbi I et al.
Clinical Pharmacology and Therapeutics, 2001
[Analysis of association between gene polymorphisms of microsomal epoxide hydrolase (EPHX1) and infant birthweight].
Wu D et al.
Yi Chuan Xue Bao = Acta Genetica Sinica, 2001
[STR polymorphisms in five Chinese ethnic groups(2)].
Li SB et al.
Yi Chuan Xue Bao = Acta Genetica Sinica, 2000
[DNA polymorphisms and haplotypes in the apoAI-CIII gene region and coronary heart disease].
Meng X et al.
Yi Chuan Xue Bao = Acta Genetica Sinica, 1990